MedTrace Logo

Infusion Treatments of Chronic Peripheral Neuropathic Pain

NCT06297915 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 102

Last updated 2024-03-07

No results posted yet for this study

Summary

This study aimed to evaluate and compare the efficacy of ketamine and lidocaine infusion in patients with chronic peripheral neuropathic pain.

Patients who received intravenous ketamine infusion and the other patient group who received intravenous lidocaine infusion were evaluated in the study. Pain scores and quality of life were assessed with scales before treatment at two weeks, two months, and six months after treatment.

Conditions

  • Neuropathic Pain

Interventions

DRUG

Ketamine

Ketamine infusion was administered at 1 mg/kg (in 1 hour)

DRUG

Lidocain

Lidocaine infusion was administered at 3 mg/kg (in 1 hour)

Sponsors & Collaborators

  • Hacettepe University

    lead OTHER

Principal Investigators

  • Gokhan Sucu, MD · HACETTEPE UNIVERSİTY

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-05-17
Primary Completion
2023-05-10
Completion
2023-08-01

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06297915 on ClinicalTrials.gov